Leonid Beigelman serves as Executive at Aligos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Leonid Beigelman has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 20, 2020 involved exercising options for 1,437 shares valued at $0.
Leonid Beigelman currently holds 18,355 shares of Aligos Therapeutics, Inc. (ALGS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leonid Beigelman has been a net neutral trader of ALGS stock. They have purchased $0 and sold $0 worth of shares.
Leonid Beigelman's most recent insider trade was on Oct 20, 2020, when they sold 1,437 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 1,437 | $N/A | Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 3,359 | $N/A | Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 3,359 | $N/A | Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 50,781 | $N/A | Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 13,559 | $N/A | Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 13,559 | $N/A | Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 163,842 | $N/A | Discretionary |